Abstract

Trypanosoma cruzi and Toxoplasma gondii are two parasites than can be transmitted from mother to child through the placenta. However, congenital transmission rates are low for T. cruzi and high for T. gondii. Infection success or failure depends on complex parasite-host interactions in which parasites can alter host gene expression by modulating non-coding RNAs such as miRNAs. As of yet, there are no reports on altered miRNA expression in placental tissue in response to either parasite. Therefore, we infected human placental explants ex vivo by cultivation with either T. cruzi or T. gondii for 2 h. We then analyzed the miRNA expression profiles of both types of infected tissue by miRNA sequencing and quantitative PCR, sequence-based miRNA target prediction, pathway functional enrichment, and upstream regulator analysis of differentially expressed genes targeted by differentially expressed miRNAs. Both parasites induced specific miRNA profiles. GO analysis revealed that the in silico predicted targets of the differentially expressed miRNAs regulated different cellular processes involved in development and immunity, and most of the identified KEGG pathways were related to chronic diseases and infection. Considering that the differentially expressed miRNAs identified here modulated crucial host cellular targets that participate in determining the success of infection, these miRNAs might explain the differing congenital transmission rates between the two parasites. Molecules of the different pathways that are regulated by miRNAs and modulated during infection, as well as the miRNAs themselves, may be potential targets for the therapeutic control of either congenital Chagas disease or toxoplasmosis.

Highlights

  • More than one billion people worldwide are burdened by parasitic diseases [1]

  • Chagas disease (American trypanosomiasis) and toxoplasmosis are caused by Trypanosoma cruzi (T. cruzi) and Toxoplasma gondii (T. gondii), respectively [2,3,4]

  • The effects of T. cruzi and T. gondii on placental tissue were assayed in human placental explants (HPE) after a 2 h challenge with 105 parasites/ml

Read more

Summary

Introduction

More than one billion people worldwide are burdened by parasitic diseases [1]. Of these, Chagas disease (American trypanosomiasis) and toxoplasmosis are caused by Trypanosoma cruzi (T. cruzi) and Toxoplasma gondii (T. gondii), respectively [2,3,4]. T. gondii is one of the most successful parasites on earth and is estimated to infect over one billion people worldwide [7]. Both parasites can be congenitally transmitted and cause perinatal morbidity and mortality [2,3,4] but present different transmission rates. T. cruzi has a low transmission rate (1–12%) [6, 8] while T. gondii has a high transmission rate (22–72%) [3] Both parasites elicit a different local placental immune response that might be related to infection susceptibility [9, 10]. T. cruzi and T. gondi infection is related to the expression and activation of different Toll-like receptors, which in turn mediate the secretion of different cytokines and chemokines in defense against both parasites in the placenta [9, 11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call